Biogened SA Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
No of Months
12
12
12
12
12
12
Profit Before Tax
6.00
6.00
6.00
6.00
3.00
2.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
1.00
-8.00
4.00
-2.00
-1.00
2.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
10.00
1.00
12.00
4.00
2.00
7.00
Cash Flow from Investing Activities
-6.00
-5.00
-7.00
-9.00
-1.00
-1.00
Cash Flow from Financing Activities
-3.00
2.00
-1.00
3.00
0.00
-5.00
Net Cash Inflow / Outflow
0.00
-1.00
4.00
-1.00
2.00
1.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in PLN Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Biogened SA
Figures in Million
consolidated Cash Flow Results
Change(PLN)
Change(%)
Profit Before Tax
6.89954983
-14.86740931
20.00
146.41%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
1.69053115
-3.36144076
4.00
150.29%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
10.26581317
-17.73624911
27.00
157.88%
Cash Flow from Investing Activities
-6.92710306
-0.08424374
-6.00
-8122.69%
Cash Flow from Financing Activities
-3.08497671
42.14305076
-45.00
-107.32%
Net Cash Inflow / Outflow
0.2537334
24.32255791
-24.00
-98.96%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0
0
0.00
0.00%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'25
YoY Growth in year ended Dec 2025 is 530.15% vs -87.19% in Dec 2024
Dec'25
Dec'24
Change(%)
Cash Flow from Operating Activities
10.27
1.63
530.15%






